NJ State Employees Deferred Compensation Plan’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,000	Closed	-$388K	–	540
2019 Q3	$388K	Hold	4,000	–	–	0.07%	314
2019 Q2	$410K	Sell	4,000 -2,000	-33%	-$216K	0.07%	329
2019 Q1	$683K	Sell	6,000 -1,000	-14%	-$73.5K	0.12%	166
2018 Q4	$274K	Hold	7,000	–	–	0.06%	396
2018 Q3	$382K	Buy	7,000 +4,000	+133%	+$274K	0.07%	392
2018 Q2	$248K	Sell	3,000 -1,000	-25%	-$77.2K	0.04%	457
2018 Q1	$266K	Buy	+4,000	New	+$231K	0.05%	424

NJ State Employees Deferred Compensation Plan's ONCE Position: Q4 2019 in Review

NJ State Employees Deferred Compensation Plan sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 4,000 shares — an estimated $388K sold.

NJ State Employees Deferred Compensation Plan first reported a position in ONCE in Q1 2018 and held it in 7 quarters. The position peaked at $683K in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

NJ State Employees Deferred Compensation Plan reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 4,000 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $388K.
NJ State Employees Deferred Compensation Plan first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
NJ State Employees Deferred Compensation Plan's Spark Therapeutics, Inc. Common Stock position peaked at $683K in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2019, filed 31 Jan 2020.